Answers are grounded in this paper and cite their sources.
INTRODUCTION: Pathogenic variants in the LRRK2 gene represent the most common monogenic cause of Parkinson’s disease. Individual variants differ in frequency, geographical distribution and genotype-phenotype associations. Here, we report a Swiss family with multiple affected individuals carrying a very rare ROC-domain variant and provide a comprehensive characterisation of their clinical phenotype. CLINICAL FINDINGS: Age at onset was earlier than typically reported for PARK-LRRK2. Leg tremor was frequently the initial presenting symptom, followed by the development of an asymmetric akinetic-rigid syndrome with a clear dopaminergic response. Constipation was commonly reported, whereas significant cognitive symptoms were not evident. Notably, despite the high penetrance of the variant, disease progression was relatively mild. PRIMARY DIAGNOSIS: Genetic testing identified a heterozygous missense variant in the LRRK2 gene (c.4309A>C, p.(Asn1437His)), classified as likely pathogenic according to ACMG criteria. CONCLUSION: The present work expands both the geographical distribution of this rare ROC-domain variant and suggests that it may be associated with earlier onset but not necessarily greater disease severity. Continued characterisation of rare LRRK2 variants is essential for refining genotype-phenotype correlations and supporting emerging targeted therapies.
No takes yet. Share an insight, caveat, or question.
Clausen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: